CytomX Therapeutics (CTMX) Surges 214.7%: Is This an Indication of Further Gains?

CytomX Therapeutics (CTMX) shares soared 214.7% in the last trading session to close at $5.13. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 23.8% loss over the past four weeks.Last month, the company announced the dosing of the first patient in a phase I dose-escalation study evaluating its pipeline candidate, CX-2051, in patients with advanced solid tumors. This might have driven the share price rally.This biopharmaceutical c ...